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Abstract 
 
To investigate the etiology of malignant hyperthermia and central core disease, 
mouse models have recently been generated and characterized (Chelu et al., 2006).  
These RyRY522S/+ knock-in mutant mice provide an excellent tool to investigate calcium 
dysregulation, its pathological consequences, and potential therapeutic approaches.  
Skeletal muscle harboring this mutation exhibits calcium leak from internal stores and an 
increased sensitivity to activation by caffeine, voltage, and temperature (Dham et al., 
2008).  Although alterations in RyR1 channel function and resultant changes in cellular 
function have been characterized in skeletal muscle, the effects of MH mutations in RyR1 
on central nervous system function have not been investigated.  Since RyR1 is highly 
expressed in cerebellar Purkinje neurons, our goal is to investigate whether the RyRY522S/+ 
mutation causes altered calcium handling and whether potential calcium dysregulation 
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Chapter One: Introduction 
Calcium plays an important role in cellular signaling and function, yet calcium 
can also trigger pathology and cell death.  Cytosolic calcium originates from tw  main 
sources: influx of extracellular Ca2+ through voltage- or ligand-gated ion channels in the 
plasma membrane and release from intracellular Ca2+ stores through ryanodine receptor 
(RyR) or inositol 1,4,5-trisphosphate receptor (IP3R) channels in the sarcoplasmic (SR) 
or endoplasmic (ER) reticular membrane.  Cytosolic calcium can act as a second 
messenger through downstream activation of a myriad of effectors; among these targets 
are calpains and other apoptotic machinery, so free calcium must be tightly regulated.  
Extensive measures are employed by a cell to maintain calcium homeostasis, but even 
slight alterations in these tightly controlled processes can disrupt the fine balance of 
control.  Furthermore, calcium dysregulation is the underlying mechanism for a number 
of different human disorders.  Malignant hyperthermia, for example, is a skeletal muscle 
disease that is associated with disrupted function of the RyR1 in the presence of certain 
triggering agents, including volatile anesthetics, depolarizing muscle relaxants, and 
environmental or exertional heat stress (Durham et al., 2008).  The RyR1 is the “skeletal 
muscle” isoform of the RyR and is highly expressed in this tissue, but also exhibits 
limited expressions by certain cell types within the brain (Giannini et al., 1995).  
Cerebellar Purkinje neurons (PN) are one of these cell types, and calcium dysregulation 
within PNs could have profound effects on not just cellular function, but organismal 
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function as well.  Purkinje neurons are the integrator and sole output of the cerebellar 
cortex (Ito et al., 1984), therefore serving as an essential step in the cerebellar signaling 
pathway.  Disruptions in calcium signaling in these cells can result in loss of mot r
coordination and ataxia, but the specific effects of altered RyR1-mediated calcium release 
on PN and/or cerebellar function have not been determined.  Furthermore, the normal 
functional role of the RyR1 in PNs is not fully understood.  Recently, a model of 
malignant hyperthermia (MH) has been created in a knock-in mouse by substitution of a 
tyrosine for a serine at residue 522 (Y522S) in RyR1 (Chelu et al., 2006).  The function 
of the mutant form of this channel has been characterized in skeletal muscle, and the 
heterozygous form of this mutation has been shown to exhibit a decreased threshold for 
activation by agonists and an increased intracellular calcium concentratio  at 
physiological temperatures, likely due to enhanced basal channel activity of the RyR1 
(Chelu et al., 2006; Durham et al., 2008).  This “hyperactive” RyR1 could serve as a 
unique tool to assess the function of RyR1 in PNs, the effects of altered RyR1 release in 
PNs, and the neurological consequences of MH.  To understand altered function of the 
RyR1 in PNs, however, it is first important to understand what is known about the normal 
functioning of the channel. 
Ryanodine Receptor 1  
The RyR1 is a calcium release channel on the SR membrane that acts as a source of 
calcium for excitation-contraction coupling in skeletal muscle (Otsu et al., 1990).  In 
PNs, however, the function of this channel in the ER membrane is less clear.  Three 
isoforms of the RyR are expressed in mammals and each of these three isoforms 
functions as a calcium release channel.  There are two known modes of activation 
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associated with the RyR.  The first is calcium-induced calcium release (CICR), whereby 
the calcium fluxed through voltage-gated calcium channels serves as the agonist for the 
RyR (Endo, 1977).  The second is mechanical coupling, whereby membrane 
depolarization induces a conformational change in L-type voltage-gated calcium channels 
(DHPR) that triggers release of Ca2+ through the RyR1 by a direct physical interaction 
(Tanabe et al., 1990).  The RyR1 is unique in that it is the only isoform of the three 
known to be activated by mechanical coupling (Tanabe et al., 1990).   
The RyR1 was originally isolated in skeletal muscle, where it is highly expressed and 
localized to the junctional SR, defined by the close proximity of T-tubule invaginations to 
terminal cisternae of the SR.  Freeze-fracture analysis of junctions in skeletal muscle 
(Protasi et al., 1997) revealed tightly compacted, two-dimensional arrays of RyR1s on the 
SR membrane and clustering of four DHPRs, in opposition to every other RyR, in the 
sarcolemmal membrane.  Each DHPR interacts with a different subunit of the RyR1,
which is a homotetramer with a molecular mass of over 2 MDa.  Each RyR1 subunit is 
approximately 565 KDa (Inui et al., 1987; Lai et al., 1988), and this large size makes the 
RyR the largest known ion channel.  The majority of the RyR1 mass, about 80%, resides 
within the cytoplasm, while only 20% of the protein is located in the luminal and 
transmembrane space (Hamilton, 2005).  The N-terminal domain comprises the large 
cytoplasmic portion of the RyR, while the C-terminal domain forms the pore and 
transmembrane region of the channel (Fill et al., 2002).    
Regulation of this enormous channel is quite complex (Fig 1); there are three main 
regulatory domains controlled by calcium, ATP and magnesium binding, two of which 
are cytoplasmic.  The first is a high affinity, specific cytoplasmic calium activation site 
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known as the A-site, which also allows competitive binding of magnesium and 
monovalent cations (reviewed by Laver, 2005).  The second regulatory domain is a non-
specific, low affinity, inhibitory cytoplasmic region known as an I-site.  Magnesium 
potently inhibits the channel when bound to either or both sites, while calcium can act as 
both an activator and an inhibitor depending upon cytoplasmic calcium concentration 
(reviewed by Laver, 2005).  Isolated RyR1s are activated at approximately 1 µM [Ca2+] i 
and inhibited at approximately 1 mM [Ca2+] i (Meissner 1994).  There is also evidence of 
a luminal regulatory domain sensitive to calcium levels, but it is unknown exactly what 
region of the RyR1 serves as this luminal site or whether luminal regulation is ctrolled 
by an associated protein.  
                          
Figure 1: Schematic of RyR1 regulation 
Adapted from Lanner et al., 2005  
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There are two theories regarding luminal calcium regulation of the channel.  Th  first 
theory, direct luminal activation, posits that calcium binding to a regulatory domain 
within the lumen allosterically modifies A-site affinity to Mg2+ (reviewed by Laver, 
2007).  Once Mg2+ inhibition of the A-site has been relieved, calcium and ATP are free to 
bind and activate the channel.  The second theory, calcium feed-through, involves the 
release of luminal calcium through the channel when the concentration of calcium within 
the ER store is high and relieving Mg2+ inhibition by competitively binding at the A-site 
(reviewed by Laver, 2007).  These theories are not mutually exclusive, and it is more than 
likely that both play a role in RyR activation. 
One potential candidate for a luminal regulatory domain is calsequestrin.  
Calsequestrin interacts with the RyR1 in conjunction with two other proteins: junctin a d 
triadin (Zhang et al., 1997).  Calsequestrin acts as both a calcium buffer and a calcium 
sensor, and its structural arrangement is modified by luminal calcium concentration 
(Beard et al., 2009).  In the presence of low levels of luminal calcium, calsequestrin is not 
bound to calcium, dissociates from the channel complex and de-polymerizes.  At 
physiological levels of luminal calcium, approximately 1 mM, calsequestrin binds 
calcium, polymerizes and attaches to junctin and triadin.  Through its binding to junctin it 
inhibits RyR1 activity and thus maintains appropriate calcium concentrations within the 
ER.  At higher levels of calcium, calsequestrin polymers become super-compacted and 
dissociate from junctin and triadin, and the inhibition of RyR1 is removed (Beard et al., 
2004). 
The RyR is part of a macromolecular complex of proteins many of which attach to 
the large cytoplasmic scaffolding domain of the RyR.  RyR1 is known to associate with 
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PDE4D3 (bound to the receptor by mAKAP), PKA, FKBP12 (calstabin), CaM, and PP1 
(through binding to spinophilin) (Bellinger et al, 2008).  When each subunit of the RyR 
binds a calstabin molecule, the closed state of the channel is stabilized (Lanner et al., 
2005).  Calstabins also play a role in coordinating the gating of the four subunits of the 
RyR and in coupling the opening of neighboring channels (Brillantes et al., 1994; Avila 
et al., 2003).  Protein kinase A (PKA) phosphorylation of the channel on Ser 2844 can 
lower the affinity of calstabin binding and results in activation.  Hyperphosphorylatin t 
this residue causes depletion of calstabin binding and can result in calcium “leak” by 
destabilizing the closed state of the channel (Reiken et al, 2003).   
Calmodulin, another protein capable of binding to the RyR, regulates the channel 
differently dependent upon cytoplasmic calcium concentration.  Calmodulin has four 
calcium binding sites, two on the N-terminus and two on the C-terminus (reviewed in 
Jiang et al., 2010).  The N-terminal sites have a ten-fold lower calcium affinity than the 
C-terminal sites.  When calcium binds the C-terminal calcium binding domains, 
calmodulin switches from an activator into an inhibitor (Jiang et al., 2010).   
The RyR1 itself can act as a regulator of neighboring RyR1s.  Calcium released 
through an individual channel will not affect that same channel since the A-site is 
inaccessible to calcium feedthrough while in an open configuration (Laver et al., 2004).  
This calcium does have an effect on neighboring channels, however, and removes Mg2+ 
inhibition by competitively binding at the A-sites.  
Even with this extensive regulation of the RyR, however, a single point mutation 
within the channel can result in severe pathology.  Missense mutations in the RyR1 can 
result in malignant hyperthermia (MH), central core disease, and multi- ini core disorder 
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(Betzenhauser and Marks, 2010).  MH is a disorder characterized by an increased 
sensitivity of the RyR1 to activation, and mouse models of MH have recently been 
created and characterized in skeletal muscle (Chelu et al., 2006; Durham et al., 2008).   
Malignant Hyperthermia 
Malignant hyperthermia is a pharmacogenetic disorder, meaning that it is 
hereditary but the major symptoms are not overtly expressed unless the individual is 
exposed to volatile anesthetics, depolarizing muscle relaxants, or heat stress. Th  
incidence of diagnosed anesthetic-induced MH is approximately 1 in 14,000 for the 
pediatric population and 1 in 50,000 for the adult population (MacLennan, 1992).  MH 
susceptibility may actually be closer to 1 in 2,000-3,000 since prevalence is difficult to 
determine; MH is only apparent after exposure to triggering agents (Monnier et al., 
2002).  However, diagnosis is possible using the in vitro contracture test prior to 
administering anesthesia.  Biopsied skeletal muscle fibers are submerged in baths 
containing either halothane or caffeine, and if the muscle cells are hypersensitive to both 
of these agents, the individual will be diagnosed as malignant hyperthermia susceptible 
(MHS).  When an MHS individual undergoes anesthesia, the RyR1 releases excessiv  
amounts of calcium from the SR, resulting in sustained whole-body muscle contracture, 
elevated body temperature, and rhabdomyolysis; without treatment this is a fatal response 
in 80% of cases (reviewed by Lanner et al., 2010).  Currently, dantrolene, an RyR 
antagonist, is the only known treatment for MH (reviewed by Lanner et al., 2010).  
Although mutations in the DHPR can result in MH (Carpenter et al., 2009), missense 
mutations in the RyR1 are the main cause of the disorder.  There are three differnt 
regions within the RyR1 which account for the loci of the vast majority of MH mutations.  
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These regions include the N-terminus, a myo/cytoplasmic domain, and a small portion of 
the C-terminus which resides in the lumen of the ER/SR (McCarthy et al., 2000).  The 
RyR1Y522S/+ mutation is located within the N-terminal domain  
There are two different mechanisms theorized to underlie MH and/or CCD; the 
“leaky” RyR1 hypothesis, and the excitation-contraction uncoupling hypothesis (Dirk en 
and Avila, 2002).  The Y523S mutation in the RyR1, the human equivalent of the Y522S 
mutation in mice, has been attributed to the “leaky” hypothesis (Dirksen and Avila, 
2002).  In most MH mutations, this leak can for the most part be compensated for by the 
calcium reuptake, extrusion and buffering machinery of the cell (Bellinger et al., 2008; 
Dirksen and Avila, 2002).  Thus, SR calcium stores remain relatively full and basal 
cytoplasmic calcium levels close to normal.  However, uncompensated calcium leak can 
result in CCD (Bellinger et al., 2008).  Thus, calcium store depletion ensues, leaving little 
calcium for release during stimulation and subsequently only weak muscle contracti . 
A number of proposed mechanisms for the cause of leaky RyR1 exist, and leaky 
RyRs have actually been associated with a number of different disorders.  The Y522S-
RyR1 mutation, associated with MH in mice, causes a calcium leak through the RyR1 
that results in an elevated intracellular calcium concentration triggering the production of 
reactive nitrogen species (RNS) by nitric oxide synthases (NOS) (Durham et l., 2008).  
An increased basal level of RNS results in S- itrosylation of the RyR1, which actually 
serves to amplify the inherent leak present in mutant channels (Durham et al, 2008).  
Calcium leak through the RyR1 (due to either an MH or CCD mutation) alters the normal 
functioning of skeletal muscle cells in multiple ways including a reduced threshold for 
luminal Ca2+ activation (Jiang et al., 2008), an altered retrograde signal from RyR1 to the 
9 
DHPR which results in a leftward shift in DHPR inactivation and window calcium 
release (Andronache et al., 2009), enhanced excitation-coupled Ca2+ entry 
(Cherednichenko et al., 2008), and altered sensitivity to temperature, activators, and 
redox modifications (Durham et al., 2008).  The phenotype of this disorder has been well 
characterized in skeletal muscle, but RyR1 is also expressed in a number of different 
tissues including cerebellar PNs (Fig 2; Giannini et al., 1995).  PNs are an extensively 
studied cell type, and calcium signaling within these cells is essential for normal 
functioning of the entire cerebellum, yet the specific role of RyR1 is not fully understood.  
An MH mutation in the RyR1 could serve as a unique tool to study altered RyR1 channel 
function in PNs.  
                  
Figure 2: RyR1 is expressed in the cerebellum 
Adapted from Giannini et al., 1995   
 
Purkinje neurons 
Purkinje neurons are the integrator and sole-output of the cerebellar cortex (Ito, 
1984).  Four types of cells provide input to PNs (Schilling et al., 2008).  Two inputs are 
inhibitory, GABA-ergic synapses: stellate and basket cells. The ot r two of these inputs 
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are excitatory, glutamatergic synapses: parallel fibers, originating from granule neurons, 
and climbing fibers, originating from the inferior olive.   
The first input, parallel fibers, synapse onto the dendrites of PNs and elicit two 
different types of responses.  A single stimulus from the parallel fiber produces only 
small and local Ca2+ signals in PNs (Eilers et al., 1995).  Repetitive parallel fiber stimuli 
create a biphasic Ca2+ response “the simple spike” (Fig 3; reviewed by Hartmann and 
Konnerth, 2005).  The first phase is the result of Na+ currents through the AMPAR that 
depolarize the membrane and trigger Ca2+ entry through voltage gated P-type calcium 
channels.  The second phase of the response is mediated by mGluR1 activation which in 
turn triggers the release of the G-proteins Gαq and Gα11.  Phospholipase Cβ, which is 
activated by the G-proteins, cleaves IP3 from PIP2 and thus triggers calcium release 
through the IP3R (Hartmann et al., 2005).  Even this second type of response is local and 
remains in small dendritic regions and sometimes even single spin s (Hartmann et al., 
2005).  Recent evidence suggests that RyRs may play a role in amplifying the second 
phase of this response through CICR.  If a dendritic spine receives a strong enough 
repetitive stimulus, calcium fluxed into the cell through VGCCs and released through the 
IP3R can diffuse out of the spine and into the dendritic shaft where RyRs are located.  
Resultant CICR through the RyRs is thought to be responsible for spreading the signal to 
other parts of the dendritic tree (Eilers et al., 1996).  
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Figure 3: Calcium signaling in cerebellar Purkinje neurons 
Adapted from Hartmann and Konnerth 2005, 
Left: Schematic of the calcium response to AMPAR activation.   
Right: Schematic of the calcium response to mGluR1 activation.  
 
The second input, climbing fiber activation or “the complex spike”, on the o r 
hand, results in a widespread signal that originates in the proximal dendrites (where 
climbing fibers synapse) and can be carried into the soma and the dis al portions of the 
dendritic tree (Eilers et al., 1996).  Presynaptic release of glutamate initiates the complex 
spike by activation of AMPARs and mGluR1s located on the postsynaptic PN plasma 
membrane.  This triggers fast, inactivating sodium currents which are responsible for the 
initial fast components of the spike.  Slow, non-inactivating sodium currents, P/Q-type 
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currents, and T-type currents shape the slower complex spike components.  Finally, K+ 
currents are mainly responsible for the repolarization of the complex s ike, but have been 
implicated in a number of other roles (Schmolesky et al., 2002).  Approximately 50% of 
the K+ current is the result of calcium-dependent potassium current activation 
(Schmolesky et al., 2002), and it has recently been suggested that RyR-mediated calcium 
stores might be a contributing source of calcium to these channels (Edgerton and 
Reinhart, 2003; Gruol et al., 1996;  Brorson et al., 1991).  There is also evidence that 
RyRs contribute to calcium signals evoked by both mGluR and AMPAR activation 
(Gruol et al, 1996). 
There are two major GABA-ergic inhibitory synapses on Purkinje neuro s; 
stellate cells, which synapse onto dendritic regions of the PNs and are located in the 
molecular layer of the cerebellum, and basket cells, which synapse onto the soma and 
proximal dendrite and are located in the molecular layer as well, but are closer to the 
Purkinje cell layer than stellate cells (Schilling et al., 2008).  Signals from these four 
regulators of PNs are integrated and sent to the deep cerebellar nuclei where PN GABA-
ergic axonal projections synapse.   
Release of calcium from intracellular stores is immensely important for the 
calcium dynamics of PNs.  The ER stores themselves form a continuous network 
throughout PNs, and are present even within dendritic spines (Terasaki et al., 1994).  The 
IP3R is also expressed throughout the cell and into the spines, while the RyR1 is 
expressed everywhere except the spines (Martone et al., 1993).  Another i dication of the 
importance of calcium signaling within these cells is the great capability of these cells to 
regulate free calcium.  Calbindin D28K and parvalbumin, endogenous, cytosolic calcium 
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buffering proteins, are very highly expressed in Purkinje neurons (Celio, 1990), and these 
two proteins along with the contribution of immobile calcium buffering machinery 
account for an enormously high calcium buffering capacity within Purkinje neurons 
(Fiero et al., 1996).  The calcium binding ratio of PNs is about an order of magnitude 
higher than other neuronal cell types.  Calcium signaling can also be important for 
nuclear functions.  Calcium signals originating from depolarization of the plasma 
membrane can reach the nucleus; RyRs amplify these somatic calcium signals and set the 
gain of nuclear calcium signals (Gruol et al., 2010).   
The RyR plays a diverse number of roles in different cells, but the specific 
contribution of the RyR1 within PNs has yet to be elucidated.  Since RyR2 and RyR3 are 
much more prevalent in other neuronal cell types, this begs the question: why are RyR1s 
expressed in PNs?  Using the recently created mouse model of MH, Y522S-RyR1, we 
hope to learn more about the function of this specific channel in the brain.  This study 
shows that the MH mutant form of RyR1 exhibits an enhanced leak through the RyR1 at 
elevated temperatures, and a decreased threshold for activation by caffeine.  RyR1Y522S/+ 
mutant mice are, therefore, a unique tool that can be used in future studi s to examine the 









Chapter Two: Methods 
Genotyping of Y522S-RyR1 mice 
The protocol for genotyping of Y522S-RyR1 mice was modified from the 
procedures described by Chelu et al., 2006.  Genomic DNA was isolated from ear 
punches using the Promega Wizard SV Genomic DNA Purification System (Promega 
Corporation) and subjected to PCR with primers (Invitrogen).  Amplified DNA was 
cleaned using an E.Z.N.A Cycle Pure Kit (Omega bio-tek), and digested with Blp1. 
Digested samples were run on a 1.5% agarose gel containing ethidium bromide (110 mV 
for 30 minutes).  Imaging of the gel was accomplished using a Bio-Rad chemi-doc 
system. 
Dissociation of cerebellar cells 
Two to three week old wild-type and Y522S-RyR1 mice were cervically 
dislocated, and cerebella were quickly dissected and submerged in ice-cold calium and 
magnesium free phosphate-buffered saline (CMF-PBS).  Meninges were removed and 
cerebella were transferred to a fresh culture dish containing a 0.1% papain solution and 
minced.  These dishes were then placed into a 37˚C incubator for 45 minutes, with 
agitation every 10-15 minutes.  After the incubation period, the cerebellar pieces w r  
rinsed twice with CMF-PBS and transferred to clinical centrifuge tubes containing 2 mL 
of dissociation media.  Cells were mechanically separated by trituration with three 
increasingly small diameter fire-polished Pasteur pipettes.  Cerebellar c ll suspensions 
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were then filtered through a 50 µm BD Falcon cell filter and collected.  Cells were then 
plated on poly-ethylene imine coated glass cover-slip culture dishes (density of 3x106 
cells/mL), and incubated at 37˚C overnight.   
Identification of dissociated Purkinje neurons 
PNs were visually identified by their large soma and apical dendritic stump.  
Visual identification of PNs was confirmed by immunocytochemistry (Fig4).  PNs are 
the only cerebellar cell to express the calcium buffering protein calbindin D28K, and 
antibodies to this PN specific protein can be utilized to determine cellular identity.  
Cerebella were dissociated and plated on glass-insert cover-slip dishes as describe  
previously and fixed in 4% paraformaldehyde.  These dishes were then rinsed repeatedly 
over a thirty minute period with PBS.  Non-specific binding was prevented by incubation 
in a blocking solution (5% BSA/0.2% Triton X-100 in PBS).  Following the blocking 
step, dishes were incubated overnight at 4˚C with anti-calbindin D28K primary 
antibodies (Millipore; 1:1000 in blocking solution, rabbit-α-mouse).  Fluorescence from 
conjugated secondary antibodies (Alexa-fluor 488; 1:1000 in blocking solution, goat-α-
rabbit) was detected with a Hamamatsu CCD camera and analyzed using Slidebook 
software (Intelligent Imaging Innovations).   
 
Figure 4: Visual identification of dissociated Purkinje neurons 
Cerebellar cells isolated from a 3 week old Y522S
18 hours. Standard immunochemical procedures were used to stain Purkinje cells 
with a calbindin-D28K antibody.  Scale bar = 20 µm. 
 
Immunohistochemistry 
 Cerebella were fixed in 4% paraformaldehyde, paraffin
sagittally (10 µm) on a microtome.  
a blocking solution (5% BSA/0.2% Triton X
incubated with anti-calbindin D28K
mouse), a well-established
secondary antibodies (Alexa
cerebellar slices were imaged on a confocal microscope using Olympus Fluo
software.   
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Calcium Imaging Experiments  
Cerebellar Purkinje cells were dissociated and plated as previously described.  
Twelve to twenty four hours after plating, neurons were loaded with the membrane-
permeable Ca2+ indicator dye, Fura-2 AM (5 µM; 30 minutes at RT).  Cells were then 
rinsed three times with rodent ringer’s solution (in mM: 145 NaCl, 5 KCl, 2 CaCl2, 1 
MgCl2, 10 HEPES, 10 glucose, pH 7.4)  and incubated at room temperature for at least 
another 15 minutes to allow for de-esterification of the Fura-2 AM. Following this 
incubation, dishes were imaged on an Olympus microscope with a Hamamatsu CCD 
camera using Slidebook software (Intelligent Imaging Innovations).  Changes of 
intracellular calcium levels in Purkinje cell somata were measured with dual excitation 
wavelength ratiometric imaging (340/380 nm excitation ratio) and expressed eith r as the 
raw F340/380 ratio or the change in F340/380 ratio (∆Ratio= Rtest-Rbaseline).  All measured 
responses were below the saturation point of Fura-2.  All recordings were made using a
40x dry objective and images were taken every second with a 100 millisecond exposure 
to 340/380 excitation. Images were binned 4x4.  For experiments using a 37˚C bath, 
temperatures were controlled with an automatic temperature controller (Warner 
Instrument Corporation).  All solutions used in calcium imaging were prepared in regular 
rodent ringer’s (RR) solution containing (in mM) 145 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 
HEPES, 10 glucose, pH 7.4.  Nominally calcium-free RR solutions were prepared with 
equimolar substitutions of MgCl2 for CaCl2 and the addition of 1 mM EGTA.   
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Dose response to caffeine 
Caffeine solutions were prepared in regular rodent ringer’s solution at 
concentrations of (in mM) 1, 5, 10, 30, and 50, and applied to dissociated PNs that were 
loaded with Fura-2 AM as previously described.  Caffeine solutions were applied with a
fast multi-barrel perfusion system.  PNs were either sequentially exposd t  increasing 
concentrations of caffeine or exposed to an individual application of one of the caffeine 
concentrations.  The duration of caffeine application was 60 seconds followed by at least
60 seconds of wash-out with regular rodent ringer’s solution.   
Depolarization-induced calcium release 
Dissociated PNs loaded with Fura-2 AM were depolarized by a 10 second puff-
application of a high K+ (80 mM) rodent ringer’s solution.  PNs were depolarized at room 
temperature and then again at 37˚C. 
Store content and SOCE 
Dissociated PNs were loaded with Fura-2 AM as described previously, but were 
rinsed with nominally calcium-free rodent ringer’s solution prior to imaging.  Baseline 
F340/380 ratios were recorded for at least a minute prior to application of 1 µM 
thapsigargin (in calcium-free RR).  For store-operated calcium entry (SOCE), after the 
F340/380 ratio had returned to baseline, a 2 mM calcium RR solution was applied for 90 
seconds. 
Statistical Analysis 
All statistical analyses were performed using the unpaired Student’s t test, unless 
otherwise stated.  Area under the curve was determined by calculating ∆F340/380 ratios 
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(∆Ratio = Rtest-Rbaseline) for every data point recorded and summing all appropriate values 
for each trial.  Full-duration at half maximal amplitude was determined by counting the 
number of data points for a given trace that were larger than the half maximal response.  
Since data were recorded once every second this value was reported in seconds.  The 
same analysis was performed for full-duration at one-tenth maximal amplitude, except 
that the data points that were counted corresponded to values larger than one-tenth of the 





















Chapter Three: Results 
Cerebellar structure and Purkinje cell morphology is not grossly altered in Y522S-
RyR1/+ mice 
The first aim of our study was to determine if the morphology of Purkinje neurons 
was altered in Y522S-RyR1 mice compared to wild-type as a result of altered RyR1 
channel function.  We did not observe any gross morphological defects in Y522S-RyR1 
PNs, as we expected (Fig 5).  This is consistent with findings in skeletal muscle.  There 
are no major structural deficits in RYRY522S/+ myotubes, although this mutation is 
associated with development of abnormal mitochondrial morphology in adult cells 




Figure 5: Morphology of RyR1-Y522S/+ Purkinje neurons 
Confocal microscopy of cerebellar section stained with antibody to the ‘Purkinje 
cell marker’ calbindin-D28K (blue staining is nuclear staining with DAPI).  
Images are z-compressions of several confocal optical sections from a wild-type 
(Wt) or Y522S-RyR1/+ (Hz) cerebellum.  Scale bar = 50 µm (top) and = 30 µm 
(bottom).  
 
Decreased threshold for activation in RyR1-Y522S/+ channels 
One of the hallmark traits of MH is that the RyR1 in skeletal muscle cells exhibits 
an increased sensitivity to caffeine (Chelu et al., 2006), and, as mentioned previously, this 
increased sensitivity can be used as a measure to diagnose MHS (Allen et al., 1998).  
 
22 
Whether the RyR1Y522S/+ mutation exhibits similarly altered function within the central 
nervous system has not, to our knowledge, been addressed. 
In order to ascertain the functional effects of this mutation on channel activity 
within PNs, we exposed dissociated cells to the RyR1 agonist caffeine and recorded the 
size of the associated calcium transient as the change in F340/380 ratios from baseline.  
Specifically, regular rodent ringer’s (RR) solutions containing increasing co centrations 
of caffeine (in mM: 1, 5, 10 and 30) were sequentially perfused onto PNs from wild-type 
and RyR1Y522S/+ mice for 60 seconds followed by a 60 second wash period with RR.  To 
ensure that sequential (seq) applications of caffeine were not depleting the ER store, we 
also perfused cells with an individual (ind) 60 second application of only one of the 
caffeine containing solutions (Fig 6).  We compared the responses from both of these 
experimental paradigms in RyR1Y522S/+ neurons and found no significant differences in 
the size of the response (change in F340/380 ratio from baseline), or the sensitivity of the 
channel to caffeine (EC-50) (Fig 6).  Interestingly, while the size of the responses were 
also unchanged between the ind and seq trials in wild-type neurons, the average EC-50 of 
wild-type cells perfused with only an individual caffeine solution is less than in the 
sequential trials (ind=12.8±5.8, seq=30.3±4.3).  However, the EC-50 from either wild-
type trial was larger than the EC-50 from the RyR1Y522S/+ trials (Fig 6).  We decided to 
pool the data from both the seq trial and the ind because the responses were not 
significantly different in size and sequential applications did not appear to be depleting 




Figure 6: Individual versus sequential caffeine dose response 
(A, B) Dissociated Purkinje neurons were perfused with a single concentration of 
caffeine (ind) or with sequentially applied (seq) increasing concentrations of 
caffeine (1, 5, 10, 30 mM) and the change in fluorescence was measured using the 
ratiometric calcium indicator dye Fura-2 in wild-type (ind, n=25, 14, 17, 19; seq, 
n=20) (A), and Y522S (ind, n=27, 16, 22, 34; seq, n=27) (B) neurons.  (C) Curves 
were fit to the data using the “Michaelis-Menton” function in Kaleidagraph.  To 
show the leftward shift in the Y522S trials more clearly, the data was normalized 
to the response to 30 mM caffeine, which was set to 1.  The responses to all other 





F340/380 ratio.  The data from the ind and seq trials were pooled (pool) and 
shown on this graph as well.  (D) Summary graph showing the calculated EC-50 
values ± parameter error generated by Kaleidagraph.   
 
We compared the responses from wild-type and RyRY522S/+ neurons and although 
the size of the calcium transient in response to each the four caffeine solutions is not 
significantly different between RyR1Y522S/+ neurons and wild-type neurons, the dose that 
invokes maximal release is reduced in RyR1Y522S/+ cells.  The maximal response to 
caffeine (30 mM) is not significantly larger than the response to 5 mM caffeine in 
RyR1Y522S/+ neurons (ts=0.841, df=106, p>0.05), indicating that at 5 mM caffeine 
RyR1Y522S/+ neurons are maximally activated.  However, in wild-type cells, the response 
to 5 mM caffeine is significantly lower than the response to 30 mM caffeine (ts=2.871, 
df=51, p<.01), indicating that maximal activation of wild-type cells is not achieved until 
the application of 30 mM caffeine.  The fact that RyR1Y522s/+ neurons are maximally 
activated by lower concentrations of caffeine supports the apparent leftward shift in EC-
50 (Wt=21.1±5.5, Y522S=3.8±1.7) exhibited by RyR1Y522S/+ cells (Fig 7).   
Since sensitivity to activation is affected by temperature in RyR1Y522S/+ myotubes 
(Durham et al., 2008), we also performed this experiment at more physiological 
temperatures (37˚C).  At this temperature, there were no significant differences between 
wild-type and RyR1Y522S/+ neurons.  The presence of any difference might have been 
obscured by the leftward shift in the EC-50 of wild-type cells (Wt 25=21.1±5.5, Wt 
37=3.1±1.9) as a result of the temperature increase.  Furthermore, the EC-50 for both 
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wild-type and Y522S cells at 37˚C (Wt=3.1±1.9, Y522S=2.1±1.3) both fell between the 
two lowest concentrations of caffeine applied (1 mM and 5 mM)  to the cells.   Future 
experiments need to be performed with lower concentrations of caffeine, to d termine 
whether there is a difference in activation at this temperature.  Although the EC-50 at 
37˚C is not significantly shifted, RyR1Y522S/+ PNs exhibited an increase in the amplitude 
of their response to 1 mM caffeine (ts=1.939, df=54, p<.05) when compared to the 
amplitude of the response in wild-type cells. These data do suggest, however, that at 25˚C 
there is a decreased threshold for activation. 
 
 
Figure 7: Decreased threshold for activation in RyR1
(A) Dissociated Purkinje neurons were perfused with increasing concentrations of 
caffeine (1, 5, 10, 
fluorescence was measured using the ratiometric calcium indic
(Wild-type, n=24, 34






and 30 mM) at 25 degrees Celsius and the change in 
ator dye Fura
, 37, 39; Y522S-RyR1, n= 27, 43, 49, 61). (B)








5, 10, and 30 mM) at 37 degrees Celsius. The response to 1 mM caffeine was 
significantly larger in Y522S neurons (unpaired t test, ts=2.266, df=57, P<0.05).  
(Wild-type, n=31; Y522S-RyR1, n=38) (C) Summary graph comparing the EC-50 
of curves fit to the data in Kaleidagraph using the “Michaelis-Menton” functio .  
Data are reported as the EC-50 ± the parameter error generated by Kaleidagraph. 
(D) Representative traces of the responses at both temperatures for both wild-type 
and Y522S neurons.  Axis labels indicate the change in F340/380 ratio (∆F) and 
caffeine concentration ([Caff]).  Data in (A) and (B) are presented as the mean ± 
SEM. 
          
Increased intracellular calcium concentration in RyR1-Y522S/+ Purkinje neurons 
The RyR1Y522S/+ mutation causes a decrease in the threshold for activation of the 
RyR1 in PNs (Fig 7), suggesting that basal RyR1 activity might also be increased.  If the 
calcium buffering, extrusion, and sequestration machinery of the cell is not able to 
compensate for enhanced activity of the RyR channel, this could result in an increase in 
basal cytoplasmic calcium concentrations.  In order to investigate whether alter d RyR1 
activation affects cytoplasmic calcium concentrations in PNs, we measured bas line 
F340/380 ratios in wild-type and RyR1Y522S/+ neurons.  Baselines were recorded for 30 
seconds at room temperature (25˚C) and more physiological temperatures (37˚C).  There 
were no significant differences in F340/380 ratios at room temperature, but at elevated 
temperature, the RyR1Y522S/+ neurons exhibited increased intracellular calcium 
concentrations (Fig 8).  PNs, therefore, are either capable of compensating for a slight 
 
28 
increase in basal RyR1 activity at lower temperatures or RyR1 activity i self is not 
enhanced without the challenge of elevated temperature. 
 
Figure 8: Increased intracellular calcium concentration in RyR-Y522S/+ 
Purkinje neurons  
Baseline fluorescence ratios, measured using Fura-2-AM, were recorded at oom 
temperature and more physiological temperatures. There is a significant 
difference in intracellular calcium levels between wild-type (n=19) and Y522S-
RyR1 (n=22) cells at 37°C (unpaired t test; ts=1.828, df=23, P<0.05). Data are 
presented as the mean ± SEM.  
 





Intracellular calcium stores are unaffected by the RyR1-Y522S/+ mutation  
The ER serves as a source of calcium for a number of different vital cellular 
functions, and calcium release from the ER can be mediated by RyR calcium channels 
(Simpson et al., 1995).  Chronically hyperactive RyR1 channels could potentially deplete 
the ER of calcium, and indirectly affect a diversity of cellular functions.  Since 
RyR1Y522S/+ PNs appear to exhibit a decreased threshold for activation and an increased 
cytoplasmic calcium concentration at higher temperatures, there is a possibility that the 
ER calcium store content could be affected by this mutation.  To address this issue, we 
took a two-fold approach.  First, we examined whether maximal calcium release from 
RyR1-mediated calcium stores was altered by the RyR1Y522S/+ mutation.  Dissociated 
wild-type and RyR1Y522S/+  PNs were perfused with a RR solution containing 30 mM 
caffeine for 60 seconds, and F340/380 ratios were recorded at both 25˚C and 37˚C.  The 
amplitude of the response was measured as the change in F340/380 ratio from baseline, 
and the amount of calcium released was indirectly measured as the area under the curve.  
There were no significant differences between the responses of wild-type and RyR1Y522S/+ 
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Figure 9: ER calcium store content is unaffected by the RyR1Y522S/+ mutation 
as assessed by maximal doses of caffeine 
(A) Representative traces from wild-type (25, n=23; 37, n=31) and Y522S (25, 
n=39; 37, n=38) Purkinje neurons that were loaded with Fura-2-AM and perfused 
with maximally activating concentrations of caffeine (30 mM) for 60 seconds.  
This experiment was performed at room temperature (25) and more physiological 
temperatures (37).  Bars indicate duration of caffeine application. (B) The change 
in F340/380 ratio from baseline.   There was no significant difference in the 
amplitude of the response in any condition (p>0.05).  (C)  Area under the curve of 
the response.  There were also no significant differences in the overall size of the 
response (p>0.05).   Data are presented as the mean ± SEM. 
 
Our second approach involved blocking the sarcoplasmic/endoplasmic reticular 
calcium ATPase (SERCA) pharmacologically with the SERCA inhibitor, thapsig rgin.  
SERCA acts as a calcium pump that sequesters calcium into the ER store.  Without a 
functioning SERCA, calcium content in the ER cannot be replenished.  Therefore, 
activity of the RyR1 and/or IP3R will eventually completely deplete the ER of calcium.  
As mentioned previously, intracellular calcium originates from either influx across the 
plasma membrane, or release from internal stores.  To ensure that measured chang s in 
F340/380 ratios were a function of release from internal stores, we applied 1 µM 
thapsigargin to dissociated PNs bathed in a nominally calcium-free extracellular solution.  
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There were no significant differences in either the amplitude, duration at half maximal 
activation, or the area under the curve of the response to thapsigargin at either 25˚C or  
37˚C (Fig 10).  Although none of the differences were significant, it does appear that  
trend toward larger store content in RyR1Y522S/+ neurons exists.  This is surprising given 














Figure 10: Store content assessed by thapsigargin
Dissociated wild-
free extracellular solution were perfused with 1 µMthapsigargin and the resulting 







type and Y522S Purkinje cells bathed in a nominally calcium





(B). (C) The 
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∆F340/380 was not significantly different between Y522S (25, n=22; 37, n=12) 
or wild-type (25, n=24; 37, n=12) cells at either temperature.  (D) The area under 
the curve was also not significantly different between Y522S-RyR1 and wild-type 
cells.  (E) The duration of the response at half maximal activation was also 
unaffected.  Data are presented as mean ± SEM.  
 
Store-operated calcium entry - a compensatory mechanism? 
The RyR1Y522S/+ mutation causes increased RyR1 activity, therefore might be 
partially depleting ER calcium stores.  However, we did not observe any significant 
alterations in the calcium store content; measured by maximal RyR activation and 
SERCA inhibition (Fig 9 and 10).  One possibility could be activation of an ER calcium-
store refilling mechanism and store-operated calcium entry (SOCE) might serve this role.  
PNs express the principal proteins typically associated with SOCE, STIM 1 and Orai 1 
(Klejman et al., 2009).  Store depletion results in clustering of these two proteins at 
discrete puncta on the ER and plasma membranes, respectively (Klejman et al., 2009).  
The rearranged proteins trigger calcium influx that can replenish the stores.  To determine 
whether RyR1Y522S/+ neurons exhibited increased SOCE, we depleted the ER stores of 
RyR1Y522S/+ and wild-type neurons with 1 µM thapsigargin in a nominally calcium-free 
extracellular solution and measured the responses.  After calcium release from the stores 
had ceased, indicated by a return of F340/380 ratios to baseline, a 2 mM calcium solution 
was perfused into the dish and the resultant calcium response was recorded as F340/380 
ratios.  In wild-type PNs we recorded SOCE in 17 out of the 27 cells tested at 25˚C, and 2 
 
out of the 12 cells tested at 37
out of the 28 cells tested at 25
analysis on the cells tested at 37
responded for both wild-type and Y522S PNs.  For tho
calculated the amplitude of the response as the change in F340/380 ratio from baseline, 
and the area under the curve to assess the overall size of the response
amplitude nor the area of the SOCE response was sig
type and Y522S neurons at
differences in SOCE explain the normal store content in eurons exhibiting increased 






˚C.  While, in RyR1Y522S/+ PNs we recorded SOCE in 21 
˚C, and 2 out of the 12 cells tested at 37˚C.  Further 
˚C was not performed, since only 2 out of the 12 cells 
se tested at 25˚C, however, we 
.  Neither the 
nificantly different between wild







Figure 11: SOCE-a compensatory mechanism? 
Purkinje cells loaded with Fura-2-AM were bathed in nominally calcium free 
extracellular solution and perfused with 1 µM Thapsigargin (black bar).  Once the 
response F340/380 ratio had returned to baseline, the extracellular solution was 
B 
Wt 25 Y522S 25 




changed to a 2 mM calcium solution for 90 seconds (blue bar).  (A) Schematic 
representation of the experimental  paradigm.  (B)  Traces showing the change in 
F340/380 ratio from baseline in response to extracellular calcium. At 25˚C, SOCE 
occurred in 9 out of 24 wild-type and 11 out of 22 Y522S cells.  At 37˚C, SOCE 
occurred in only 2 out of the 12 cells tested for both wild-type and Y522S 
Purkinje neurons.  Neither  the amplitude (C), nor the area under the curve (D) 
were significantly different at 25˚C.  Further analysis was not performed on the 
cells tested at 37˚C because so few cells responded at this temperature.  Dta are 
presented as the mean ± SEM.  
 
Effects of altered RyR1 function on cellular function 
The effects of the RyR1Y522S/+ mutation on RyR1 function in PNs contribute to an 
apparent lower threshold for activation and, furthermore, increased basal RyR1 activity t 
physiological temperatures.  However, the implications of altered RyR1 function on more 
global calcium dynamics and cellular function in PNs are not fully understood.  Even 
though PNs express the isoform of the RyR that is typically associated with mechanical 
coupling, most evidence suggests that CICR is the main pathway for activation in these 
cells.  By depolarizing PNs with a high potassium solution, we triggered calcium infl x 
through voltage gated calcium channels.  This calcium signal would then be amplified by 
calcium-induced calcium release through the RyR1.  We measured the global cacium 
response to depolarization in Y522S and wild-type cells as a means to elucidate the 
consequences of altered RyR1 function on global calcium dynamics within PNs.  
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Specifically, F340/380 ratios were recorded at both 25˚C and 37˚C, and the amplitude of 
the response was calculated using the change in F340/380 ratio from baseline.  The 
overall size of the response was calculated using the area under the curve.  When the 
F340/380 ratio had returned to a baseline, we stopped recording the response.  In some 
cells, this baseline either overshot or undershot the original baseline.  The number of 
wild-type and RyR1Y522S/+ cells exhibiting this behavior did not appear to be different 
(Wt 25: 2/10, Y522S 25: 5/15, Wt 37: 3/10, Y522S 37: 5/15 cells). 
Since the initial phase of the response is likely due to calcium influx, and calcium 
release through the RyR1 primarily contributes in later phases of the respons, we 
measured the full duration of the curve at both one-half maximal values (FDHM) and 
one-tenth maximal values (FDTM).  The amplitude, area, and the durations of the 
response were not significantly different between wild-type and Y522S neurons (Fig 12).  
However, some interesting trends in the data exist.  The amplitude of the response 
indicates a trend toward larger initial responses in wild-type neurons than in RyR1Y522S/+ 
neurons, and this trend is reversed when comparing either the area under the curve or the 











Figure 12: Effects of the Y522S mutation on calcium dynamics 
An 80 mM K+ solution was puff applied for 10 seconds onto dissociated Purkinje  
that were loaded with Fura-2-AM and the calcium response was recorded as the 
change in F340/380 ratio from baseline. (A) Traces showing the calcium response 
to depolarization in each condition. (B) Summary graph showing the ∆F340/380 
ratio. There were no significant differences between groups at either temperature.  
(C) Summary graph displaying the area under the curve that was calculated for 
each condition.  There were no group differences for this measure.  (D, E) Graphs 





maximal activation (FDHM) or one-tenth of maximal activation (FDTM).  There 
were no significant differences between Y522S-RyR1 (n=15) and wild-type 








Chapter Four: Discussion 
The function of the RyR1 in skeletal muscle has been well established; membrane 
depolarization induces a conformational change in L-type voltage-gated calcium channels 
that, by mechanical coupling, triggers release of Ca2+ through the RyR1 (Beam and 
Horowicz, 2004).  It is unclear if the RyR1, which is highly expressed in cerebellar 
Purkinje neurons, is involved in a similar type of mechanical coupling or acts solely 
through a Ca-induced Ca2+ release mechanism.  Furthermore, the role of calcium released 
through the RyR1 is not clearly defined.  The “cardiac”- and “brain”-RyR isoforms 
(RyR2 and RyR3) are more generally expressed throughout the cerebellum, while the 
“skeletal”-isoform (RyR1) is limited in expression within the brain (Ledbetter et al., 
1994, Giannini et al., 1995).  This begs the question: does RyR1 function differently in 
Purkinje cells than RyR2 or RyR3 does in other neuronal cell types?  There are currently 
no commercially available isoform-specific pharmacologic agents directed against RyR1.  
Thus, a mutant form of the RyR1 that alters channel function could potentially serve a a 
unique tool to assess the individual contribution of this RyR isoform to PN function.   
The RyR1Y522S/+ mutation has been shown to affect RyR1 channel activity in 
skeletal muscle.  Mutant channels are hypersensitive to activation by agonists (caffeine, 
voltage, and temperature) and exhibit enhanced basal activity contributing to increased 
intracellular calcium concentrations at higher temperatures (Chelu et al., 2006; Durham et 
al., 2008).  However, to our knowledge, no previous study has examined whether MH 
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mutations exhibit similar phenotypes in non-muscle cell types.  RyR1 expressed in a 
neuronal environment might behave differently than RyR1 expressed in skeletal muscle, 
and the etiology of an MH mutation might not be restricted to skeletal muscle cells. Our 
results indicate that this mutant RyR1Y522S/+ in PNs, exhibits a decreased threshold for 
activation by caffeine, and increased basal intracellular calcium concentrations at 
physiological temperatures and therefore represents a valid tool to examine altered RyR1 
function within PNs. 
Calcium release from the ER can be induced by the RyR agonist caffeine, and an 
increased sensitivity of RyR1Y522S/+ to this compound within skeletal muscle cells has 
been well documented.  We used caffeine to determine if the RyR1Y522S/+ mutation affects 
the threshold for channel activation in PNs, and discovered that mutant channels exhibit a 
decreased threshold for activation.  However, at higher temperatures there wer no 
significant differences in the threshold for activation.  To fully understand the 
consequences of altered RyR1 activation as a result of the RyR1Y522S/+ mutation in PNs, it 
is important to distinguish what is known about RyR1 in skeletal muscle from what we 
know about RyR1 in PNs.  The regulatory proteins that are associated with RyR1 in 
skeletal muscle are not necessarily expressed in PNs.  Although, at least some of the key 
players expressed in skeletal muscle are present in PNs.  RyR1 associates with 
calsequestrin in skeletal muscle, and calsequestrin is expressed in PNs of the chicken 
(Volpe et al., 1993), but it is unclear if calsequestrin has the same functional interctions 
in PNs.  In addition, it is currently unknown if RyR1 is arranged in PNs in orderly arra s 
as it is in skeletal muscle.  RyR1s, in skeletal muscle, that are not functionally coupled to 
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neighboring channels do not maintain a stabilized closed state as well as RyR1 that are 
coupled with their neighbors (Liang et al., 2009), so this could potentially account for 
observed differences in channel function.  Another important question is whether RyR1s 
are activated by mechanical coupling or CICR in PNs.  There is strong evidence that 
RyRs in PNs are associated with CICR (Kano et al., 1995) and the presence of 
mechanical coupling is unlikely as there is no calcium release when PNs are depolariz d 
in zero extracellular calcium solution (Eilers et al., 1996). Furthermore, P-type voltage-
gated calcium channels carry ~90% of the calcium current in response to depolarizati n 
in PN and are likely the main contributors to activation of RyR1 (Mintz et al., 1992).  
While in skeletal muscle, L-type voltage-gated calcium channels physicall  interact with 
the channel and depolarization induces a conformational change in the DHPR that results 
in activation (Tanabe, 1990).  L-type voltage-gated calcium channels are also xpressed 
in PNs (Ahlijanian et al., 1990), but the function of these channels remains unclear, a 
recent study suggests a larger role for L-type channels early in development (Gruol et al., 
2006).      
Whether altered activation of the RyR1 due to the RyR1Y522S/+ mutation affects 
PN morphology is an important question to address.  MHS individuals may be suffering 
from neurological symptoms that may be overlooked, since the characteristic skeletal 
muscle defects are overshadowing.  Thus, the effects of MH mutations on cerebellar 
cellular organization and neuronal morphology need to be addressed as many processes 
involved in development are regulated by calcium.  Using confocal microscopy, we 
determined that the RyR1Y522S/+ mutation does not appear to grossly alter PN morphology 
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(Fig 4).  Previous studies of the effects of the RyR1Y522S/+ mutation on skeletal muscle 
cell morphology, revealed no major structural differences, but did find swollen and 
abnormal mitochondria in adult mutant mice due to an enhanced basal leak of calcium 
through the RyR1  (Durham et al. 2008).   
Increased intracellular calcium levels can, over time, result in excessive 
production of reactive nitrogen species (RNS) by nitric oxide synthases within the cell 
(Durham et al., 2008).  Lingering RNS can enhance S-nitrosylation of the RyR1 on cys 
3635, which lies in the calmodulin binding domain (Sun et al., 2001).  S-nitrosylation acts 
to exacerbate calcium leak through the RyR1 through two main mechanisms.  The first is 
that S-nitrosylation increases the Kd of CaCaM for the RyR1 (the calcium-bound, 
inhibitory form of calmodulin) which reduces calmodulin’s inhibitory actions on the 
channel (Boschek et al., 2007).  The second is that S-nitrosylation increases the Kd of 
calstabin for the RyR1, which destabilizes the closed state of the channel resulting in an 
enhanced leak (Bellinger et al., 2009).  In the RyR1R615C/+ porcine model of MH, it has 
been proposed that calstabin depletion interferes with the ability of RyR1 to interact with 
neighboring channels, thus leading to both enhanced calcium release in response to 
halothane, and a basal calcium leak through the RyR1 (Liang et al., 2009).  Consistent 
with the notion of an enhanced calcium leak, we observed larger Fura-2 fluorescence 
ratios at 37˚C in RyR1Y522S/+ PNs than in wild-type PNs (Fig 8).   
Even though RyR1Y522S/+ PNs exhibit a calcium leak, work in our lab has not 
detected any changes in the amount of cellular and mitochondrial stress presentin PNs.  
The levels of lipid peroxidation in RyR1Y522S/+ cerebellar neurons, as measured by MDA 
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equivalents, are not significantly different than the levels of lipid peroxidation in wild-
type neurons (Santiago and Lorenzon, unpublished data).  This suggests that the 
phenotype of MH might be more severe in skeletal muscle cells, however whole 
cerebellar lysates were used in these experiments, and since PNs only make up about 
10% of the cerebellum, actual differences in cellular stress may have been masked by the 
nature of the experiment.  Future studies will be performed on Purkinje neuron enriched 
preparations to further investigate this phenomenon.   
Lipid peroxidation is a measure of stress directly resulting from action of reactive 
oxygen species (ROS), but the negative effects of the RyR1Y522S/+ mutation within 
skeletal muscle appears to be more directly related to the action of reactive nitrogen 
species (RNS).  In order to determine if the production of RNS is enhanced in Y522S-
RyR1 PNs in response to elevated levels of calcium, isolated PNs were loaded with DAF-
FM (a NO indicator dye) and exposed to high levels of glutamatergic stimulation.  Eve  
though glutamate increased the intracellular concentration of calcium, preliminary 
experiments demonstrated that the production of NO was not significantly increased in 
either Y522S-RyR1 or wild-type neurons (Although there appeared to be a trend toward 
an increase in NO production: Santiago and Lorenzon, unpublished).  
Interestingly, it has been found that the RyR has essentially two separate release 
pathways, one that is insensitive to inhibitory concentrations of ryanodine, and one that is 
blocked by ryanodine (reviewed by Eltit et al., 2010).  The ryanodine insensitive 
conformation of the RyR1, thought to be the calcium “leak” pathway, is active at restnd 
can be blocked by bastadin 5 (Eltit et al., 2010).  This pathway is the main source for 
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maintaining resting levels of intracellular calcium, contributing approximately 50% (Eltit 
et al., 2010).  It is unclear which of these two proposed pathways are responsible for the 
MH phenotype, or whether both are involved.  Since the ryanodine-insensitive pathway 
seems to be mainly responsible for setting cytoplasmic calcium levels, it seems that the 
presence of increased intracellular calcium concentrations in RyR1Y522S/+ neurons is 
likely the result of the “leak” pathway.  The classical form of calcium release, or the 
ryanodine-sensitive pathway, might also be affected by the RyR1Y522S/+ mutation in PNs, 
because caffeine activates the RyR by increasing A-site affinity to the endogenous ligand, 
calcium (Meissner et al., 1997).  Theoretically, increases in activity of either of these 
pathways could result in increased calcium signaling, increased cytoplasmic calcium 
levels and/or a depleted ER calcium store.   
ER calcium store content does not appear to be significantly affected in PNs with 
the RyR1Y522S/+ mutation.  Even though RyR1Y522S/+ mutants exhibit hypersensitivity to 
activation, the amount of calcium released in response to maximal activation, was ot 
different.  Consistent with our results, RyR1Y522S/+ skeletal myotubes do not show 
depletion of SR calcium stores (Chelu et al., 2006).  Furthermore, the porcine model of 
MH, RyR1R615C/+, exhibits a calcium leak and an increased sensitivity to activation, but 
no depletion of calcium stores (Liang et al., 2009).  Furthermore, assessment of the 
content of the ER stores with the SERCA poison, thapsigargin, did not yield any 
significant differences between wild-type and RyR1Y522S/+ neurons.  
 One possible mechanism that could contribute to refilling the stores and 
compensation for excessive calcium leak is store-operated calcium entry (SOCE).  SOCE 
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is a pathway of calcium influx that is triggered by store depletion, and the calcium that 
enters the cytoplasm can be sequestered into the ER by SERCA.  STIM1, which resides
in the ER membrane, senses intra-luminal calcium levels and clusters to form disc ete 
puncta when calcium stores are depleted (Klejman et al., 2009).  Orai1, a protein residing 
in the plasma membrane, also forms clusters that create overlapping puncta with STIM1.  
Following protein clustering, calcium flows inward through store-operated calcium 
channels, the exact molecular make-up of these channels is still unclear, but it isthought 
that Orai1 and possibly TRPC channels can form pores in the plasma membrane that 
allows calcium flux into the cytosol (reviewed by Hewavitharana et al., 2007).  SOCE 
has not, to our knowledge, been directly measured in PNs, although STIM1 expression 
has been demonstrated in these cells (Klejman et al., 2009).  Thus, we investigated if 
SOCE is present in PNs and if SOCE is altered in RyR1Y522S/+ PNs.  PNs do express 
SOCE, but the size of the response is unchanged by altered RyR1 activity in RyR1Y522S/+ 
cells.  Furthermore, since SOCE is unchanged in RyR1Y522S/+ neurons, it is unlikely that 
this phenomenon serves as a compensatory mechanism for an enhanced leak.   
After characterizing how the RyR1Y522S/+ mutation affects channel function, we 
hoped to investigate the affects of this mutation on cellular calcium signaling by 
depolarizing RyR1Y522S/+ and wild-type PNs with a high potassium solution.  While no 
significant differences were found between F340/380 responses, there were some 
interesting trends in the data.  Wild-type responses appeared slightly larger in amplitude, 
but when examining the duration of the response this trend reverses.  Differences in 
global calcium responses might be revealed using inhibitory concentrations of ryan dine 
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during periods of depolarization; pharmacological subtraction of RyR-mediated calcium 
release might reveal more subtle differences in calcium dynamics.     
 Although the functional consequences of the RyR1Y522S/+ mutation might differ 
between cell types, the presence of an enhanced leak and an increased sensitivity to 
caffeine in PNs suggests that perhaps the MH-phenotype is not constrained solely to 
skeletal muscle.  Furthermore, this mutation represents a valuable tool to further 








Chapter Five: Summary 
Our study represents the first examination of the consequences of an MH-inducing 
mutation in a non-muscle environment.  We have found that Y522S-RyR1 PNs exhibit an 
enhanced basal leak at physiological temperatures, and an enhanced sensitivity to 
agonists without affecting store content.  In addition, SOCE does not appear to be a 
compensatory mechanism for enhanced calcium leak through the RyR1, but further 
investigation of this phenomenon is warranted.  Now that we have determined that this 
mouse model of MH is a valid tool to examine altered RyR1 function within PNs, we 
hope to determine how this mutation affects the excitability and firing behavior of the 
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